£1.83m
−12%vs Dec 2023Active10274924Private limited companyLondon
KAERUS BIOSCIENCE LIMITED
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Kaerus Bioscience Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
KAERUS BIOSCIENCE LIMITED is an active private limited company (company number 10274924) incorporated on 12 July 2016, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2024, showing net assets of £1.83m and cash of £2.06m, with 6 employees on average. Net assets fell 12% on the prior period (£2.08m).
Peer position · net assets
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
No active person with significant control is registered.
- The Cambridge Partnership Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 12 July 201610 yrs ago
- Next accounts due
- 30 September 202623 days overdue
- Confirmation statement due
- 26 July 2027in 276 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£2.06m
−17%vs Dec 2023Not reported
6
+20%vs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | £1.83m | £2.06m | — | £317k | — | — | 6 |
| 31 December 2023 | £2.08m | £2.48m | — | £598k | — | — | 5 |
Current ratio6.78Current assets ÷ creditors within one year
Cash per employee£343kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £1,831,989 at 31 December 2024
- Current assets at least 1.5× creditors within one yearCurrent ratio 6.78
- Cash at bank of £50,000 or moreCash £2,055,366
- Incorporated five or more years agoIncorporated 12 July 2016
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 276 days
- Next accounts due23 days overdue
- Accounts period endNet assets £1.83m · small accounts
- Accounts period endNet assets £2.08m · small accounts
- Incorporated
08
Similar companies in London
- ENGITIX LIMITEDLondon · inc. Jul 2016
- MEDDER CR SERVICES LTDLondon · inc. Jul 2016
- STRATIPHY CONSULTING LTDLondon · inc. Jun 2016
- GAMMADELTA THERAPEUTICS LTDLondon · inc. Jun 2016
- ONCOGEN LIMITEDLondon · inc. Aug 2016
- ELEUSIS THERAPEUTICS LTDLondon · inc. Jun 2016
All companies incorporated on 12 July 2016 · in Jul 2016.
09
Reminders for KAERUS BIOSCIENCE LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.